Dashboard
Manage Tickers

ARTL


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

artelo-biosciences-reports-phase-1-and-2-data-for-art2612-and-art2713-highlighting-safety-and-significant-weight-gain-in-cancer-anorexia-trial
Artelo Biosciences Reports Phase 1 And 2 D...
10/15/2025 13:18:39

ART26.12 Phase 1 Data Demonstrated No Safety Concerns, Predictable Linear Plasma Exposure, and Options for Dosing in Either Fed...

artelo-biosciences-prices-20m-public-offering
Artelo Biosciences Prices $2.0M Public Off...
09/30/2025 14:11:59

SOLANA BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutic...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/30/2025 12:09:34

why-wolfspeed-shares-are-trading-higher-by-over-50-here-are-20-stocks-moving-premarket
Why Wolfspeed Shares Are Trading Higher By...
09/30/2025 09:37:13

reported-earlier-artelo-biosciences-commences-underwritten-public-offering-of-common-stock-and-pre-funded-warrants
Reported Earlier, Artelo Biosciences Comme...
09/30/2025 06:34:00

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
09/19/2025 12:09:04

artelo-biosciences-announces-publication-of-new-preclinical-data-on-art1211-proprietary-cannabidioltetramethylpyrazine-cocrystal
Artelo Biosciences Announces Publication O...
09/10/2025 12:36:52

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways...

this-science-applications-international-analyst-is-no-longer-bullish-here-are-top-3-downgrades-for-monday
This Science Applications International An...
09/08/2025 13:35:13

d-boral-capital-downgrades-artelo-biosciences-to-hold
D. Boral Capital Downgrades Artelo Bioscie...
09/08/2025 11:21:26

D. Boral Capital analyst Jason Kolbert downgrades Artelo Biosciences (NASDAQ:ARTL) from Buy to Hold.

nasdaq-gains-over-100-points-science-applications-shares-fall-after-q2-results
Nasdaq Gains Over 100 Points; Science Appl...
09/04/2025 19:06:34

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 17:05:59

dow-surges-200-points-us-initial-jobless-claims-rise
Dow Surges 200 Points; US Initial Jobless ...
09/04/2025 16:37:17

artelo-biosciences-prices-640924-share-offering-at-440share-and-pre-funded-warrants-at-4399-proceeds-3m
Artelo Biosciences Prices 640,924 Share Of...
09/04/2025 12:40:23

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 12:08:12

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/03/2025 21:06:23

artelo-biosciences-announces-proposed-underwritten-public-offering-of-common-stock-andor-pre-funded-warrants-size-not-disclosed
Artelo Biosciences Announces Proposed Unde...
09/03/2025 20:38:20

artelo-biosciences-drug-helps-cancer-patients-regain-weight-eyes-licensing-deal
Artelo Biosciences Drug Helps Cancer Patie...
09/03/2025 17:45:42

Artelo Biosciences reported encouraging Phase 2 trial results for ART27.13 in cancer anorexia-cachexia syndrome, citing strong ...

artelo-biosciences-announces-interim-results-from-phase-2-cares-trial-with-art2713-peripherally-acting-cannabinoid-receptor-agonist-for-treatment-of-cacs
Artelo Biosciences Announces Interim Resul...
09/03/2025 12:47:46

Catalyst for Advancing Discussions with Pharmaceutical Companies that have Expressed Interest in ART27.13 for CACSConsistent Im...

d-boral-capital-maintains-buy-on-artelo-biosciences-maintains-18-price-target
D. Boral Capital Maintains Buy on Artelo B...
08/26/2025 11:55:01

D. Boral Capital analyst Jason Kolbert maintains Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $18 price target.

artelo-biosciences-announced-results-from-its-preliminary-food-effect-evaluation-with-art2612-as-a-part-of-the-single-ascending-dose-phase-1-trial-for-persistent-pain
Artelo Biosciences Announced Results From ...
08/25/2025 11:57:59

Safety and Pharmacokinetic Data Support Dosing of ART26.12 in Fed or Fasted ConditionsCompletion of Positive Single Ascending D...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION